SCHEMBL6172433

SCHEMBL6172433

CC(c1ccncc1NC(=O)c1cccc(Cl)c1)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.38
RXFP1 Q9HBX9 3/20 0.37
POLB P06746 1/20 0.37
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
BRAF P15056 3/20 0.34
CXCR3 P49682 1/20 0.34
MAPT P10636 4/20 0.34
GSK3B P49841 3/20 0.34
TP53 P04637 1/20 0.34
GRM5 P41594 1/20 0.34
ABL1 P00519 1/20 0.34
BCR P11274 1/20 0.34
CSF1R P07333 1/20 0.34
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173116 0.87 KCNK2 (0.38) RXFP1POLBMEN1KMT2ABRAF
SCHEMBL6175153 0.87 LIPE (0.43) POLBBRAFGSK3BGRM5ABL1
SCHEMBL6175990 0.84 KIF11 (0.37) RXFP1
SCHEMBL6174089 0.83 GAA (0.36) GAARXFP1
SCHEMBL6175133 0.83 GRM5 (0.43) POLBBRAFMAPTTP53GRM5
SCHEMBL6173219 0.82 ALDH1A1 (0.38) GAARXFP1POLBMEN1KMT2A
SCHEMBL6172120 0.82 KDM4E (0.35)
SCHEMBL6174685 0.82 RXFP1 (0.36) RXFP1
SCHEMBL6176021 0.81 IGF1R (0.34) RXFP1
SCHEMBL6171910 0.80 NAMPT (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed